Teresa Curtin

Associate Attorney

  • Focus: Defective Drugs and Devices
  • Fax: 212-344-5461
  • New York Office
    700 Broadway, New York, NY 10003

Biography

While I love the intellectual challenge of doing complicated medical device and pharmaceutical drug litigations, what motivates me and keeps me going is the opportunity to help individuals and families. I consider myself very privileged to be in the position I am to be of service to those in need.

Teresa  A. Curtin joined Weitz & Luxenberg in 2006 after 16 years as a plaintiffs’ attorney in complex civil litigations (including medical malpractice, catastrophic injuries and criminal cases) at the trial and appellate levels. She currently serves as an associate attorney in our Drugs & Medical Devices Litigation group where she has participated in all phases (from initial investigations to post-trial motions) of the Vioxx, Celebrex, Bextra, Seroquel, Ortho Evra, Yaz/Yasmin, DePuy hips, third-generation DES, and Advanced Bionics cochlear implant litigations. Ms. Curtin has also assisted our Environmental Toxic Tort Litigation group with complex environmental contamination cases involving workplace exposure to toxic substances.

At New York University School of Law, she was a Root-Tilden Snow Scholar and served on the New York University Review of Law and Social Change as both a member of its editorial staff and as colloquium editor. She also worked at the law school’s Battered Women’s Clinic, where she assisted those convicted of the death of their abusers (this experience triggered a lifelong interest in volunteering to work with domestic violence victims; most recently she trained a service dog to accompany her on visits to domestic violence shelters).

After graduation from law school, she clerked for Justice Stewart G. Pollock of the New Jersey Supreme Court. Ms. Curtin is deaf, and is fluent in American Sign Language.

Publications

  • “Preamble Preemption and the Challenged Role of Failure to Warn and Defective Design Pharmaceutical Cases in Revealing Scientific Fraud, Marketing Mischief, and Conflicts of Interest,” 35 Hofstra L. Rev. 1773 (2007)

Get the Help You Need Today

Free Case Review